|
STK4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.51950000044133E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.156770E-03 |
| Normal-vs-Stage2 |
5.135500E-03 |
| Normal-vs-Stage3 |
9.605200E-04 |
| Normal-vs-Stage4 |
9.198300E-02 |
| Stage1-vs-Stage2 |
1.511820E-01 |
| Stage1-vs-Stage3 |
2.536100E-02 |
| Stage1-vs-Stage4 |
5.083400E-01 |
| Stage2-vs-Stage3 |
2.988800E-01 |
| Stage2-vs-Stage4 |
7.416000E-01 |
| Stage3-vs-Stage4 |
3.266600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.93369999998716E-06 |
| Normal-vs-AfricanAmerican |
4.904900E-03 |
| Normal-vs-Asian |
1.883170E-01 |
| Caucasian-vs-AfricanAmerican |
8.369600E-01 |
| Caucasian-vs-Asian |
7.038600E-01 |
| AfricanAmerican-vs-Asian |
6.959000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.84030000000602E-05 |
| Normal-vs-Female |
1.47549999995888E-06 |
| Male-vs-Female |
1.383790E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.708500E-02 |
| Normal-vs-Extreme_Weight |
1.354350E-02 |
| Normal-vs-Obese |
2.17849999999409E-05 |
| Normal-vs-Extreme_Obese |
7.712000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.179800E-01 |
| Normal_Weight-vs-Obese |
1.077610E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.951200E-01 |
| Extreme_Weight-vs-Obese |
1.082200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.123000E-01 |
| Obese-vs-Extreme_Obese |
5.377500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.024800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.80859999976413E-07 |
| Normal-vs-Age(61-80Yrs) |
2.201700E-03 |
| Normal-vs-Age(81-100Yrs) |
8.380400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.420400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.671540E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.261900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.485790E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.831900E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.621700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.186900E-04 |
| Normal-VS-Type2 PRCC |
4.703600E-03 |
| Normal-VS-KIRP CIMP |
1.601480E-03 |
| Normal-VS-Unclassified PRCC |
2.19870000000011E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.846000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.64009999999282E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.402000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.830060E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.605530E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.516000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.135730E-02 |
| Normal-vs-N1 |
1.607030E-04 |
| Normal-vs-N2 |
1.240600E-01 |
| N0-vs-N1 |
7.923700E-03 |
| N0-vs-N2 |
9.901800E-01 |
| N1-vs-N2 |
2.321400E-01 |
|
|
